Open Nav

Please submit your session questions in advance at

Q BioMed Inc

  • Denis Corin, Q BioMed Inc

Q BioMed, Inc. is a biomedical acceleration and development company. We are focused on licensing and acquiring biomedical assets across the healthcare spectrum. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support and expansion capital they need to meet their developmental potential so that they can provide products to patients in need.

  • Date:Monday, February 11
  • Time:3:00 PM - 3:15 PM
  • Room:Chelsea
  • Location:7th Floor
  • Session Type:Company Presentation
  • Submission ID:23495
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Goal for Presentation:Attract investors and update shareholder and stakeholders
  • Company
  • Company HQ City:New York
  • Company HQ State:New York
  • Company HQ Country:United States
  • Market Cap:25M
  • Ticker:QBIO
  • Exchange:OTCQB
  • CEO/Top Company Official:Denis D Corin
  • Year Founded:2015
  • Main Therapeutic Focus:Multiple Therapeutics
  • Lead Product in Development:Metastron
  • Development Phase of Primary Product:Phase IV
  • Number Of Unlicensed Products (For Which You Are Seeking Partners):3
Denis Corin
Q BioMed Inc